Compare Align Technology, Inc. (ALGN) vs Procter & Gamble Co (PG) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Align Technology, Inc. vs Procter & Gamble Co — how do they compare? Align Technology, Inc. trades at $182.5 (market cap $12.86B), while Procter & Gamble Co trades at $147.38 (market cap $342.40B). The key difference: Procter & Gamble Co is far larger — about 26.6× Align Technology, Inc.'s market cap, and Procter & Gamble Co pays a 2.9% dividend while Align Technology, Inc. pays none. Which is the better fit depends on your goals.
| ALGN | PG | |
|---|---|---|
Market Cap | $12.86B | $342.40B |
Sector | Health | Consumer Staples |
52-Week High | $207.19 | $167.18 |
52-Week Low | $124.88 | $138.10 |
Enterprise Value | $11.92B | $367.88B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Align Technology (ALGN) trades at $179.45, up 0.72% with a bullish technical outlook from moving averages. The company maintains solid profitability with a 10.5% net margin and has beaten EPS estimates for three consecutive quarters. Recent developments include a new manufacturing facility in India and upcoming Q2 2026 earnings on July 29, 2026.
ALGN offers growth potential with a consensus price target of $218.40, representing 22% upside, supported by 73% analyst buy ratings. Risks include European regulatory scrutiny and North American demand pressures. The stock's valuation at 30x P/E requires sustained earnings growth to justify further gains.
Procter & Gamble (PG) trades at $147.36, up 0.22% on the day, with a bearish technical signal but strong fundamentals including consistent earnings beats and a 19.16% net margin. The stock shows stable revenue growth, with 2025 revenue at $84.28B, and benefits from a recent dividend payment of $1.09 per share. Analyst consensus is bullish with a $159.75 price target, though technical indicators highlight resistance near $148.
PG offers a defensive investment with reliable dividends and solid cash flow, but faces risks from premium valuation and modest growth. Near-term upside depends on Q2 2026 earnings meeting expectations, while macroeconomic pressures could limit gains. Institutional sentiment remains positive, supporting a hold or buy stance for long-term investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Align Technology, Inc.
Align is the leading manufacturer of clear dental aligners globally, having pioneered the technology with the introduction of its Invisalign branded aligners in 1998. Since then, Invisalign has become a household name, having treated over 10 million patients with malocclusion (misaligned teeth) through orthodontist and dentist-guided treatment plans. The company maintains dominant market share of clear aligners, despite the introduction of direct-to-consumer competitors upon the expiration of key patents that began in 2017. Align also manufactures intraoral scanners (iTero), used for orthodontic treatment and restorative dental procedures (digital models for crowns, veneers, and implants).
Read more on ALGN →About Procter & Gamble Co
The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →
